Lori Lawley

Finanzdirektor/CFO bei LUMOS PHARMA, INC.

42 Jahre

Health Technology

Commercial Services

Consumer Services

Profil

Lori Lawley is currently Chief Financial Officer & Secretary at Lumos Pharma, Inc. since 2020.
Former positions include Vice President-Finance & Controller at NewLink Genetics Corp.
from 2018 to 2020 and Senior Manager at Ernst & Young LLP from 2014 to 2015.
Education includes undergraduate and graduate degrees from McCombs School of Business.

Aktive Positionen von Lori Lawley

Unternehmen	Position	Beginn
LUMOS PHARMA, INC.	Finanzdirektor/CFO	04.07.2021

Alle aktiven Positionen von Lori Lawley

Ehemalige bekannte Positionen von Lori Lawley

Unternehmen	Position	Ende
LUMOS PHARMA, INC.	Comptroller/Controller/Auditor	01.03.2020
Ernst & Young LLP Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services	Corporate Officer/Principal	01.04.2015

Sehen Sie sich die Erfahrung von Lori Lawley im Detail an

Ausbildung von Lori Lawley

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Lori Lawley im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	4
Ernst & Young LLP Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services	Commercial Services
NewLink Genetics Corp. NewLink Genetics Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops, and commercializes novel immunotherapeutic products for treatment of cancer	Health Technology
McCombs School of Business McCombs School of Business Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Lumos Pharma, Inc. Lumos Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops and markets therapeutics for rare diseases	Health Technology